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Abstract
Background: In 2007, universal screening for gestational diabetes mellitus (GDM) was introduced in Tamil Nadu,
India. To identify factors hindering or facilitating timely initiation and completion of the GDM screening and diagnosis
process, our study investigated how pregnant women in rural and urban Tamil Nadu access and navigate different
GDM related health services.
Methods: The study was carried out in two settings: an urban private diabetes centre and a rural government primary
health centre. Observations of the process of screening and diagnosis at the health centres as well as semi-structured
interviews with 30 pregnant women and nine health care providers were conducted. Data was analysed using
qualitative content analysis.
Results: There were significant differences in the process of GDM screening and diagnosis in the urban and rural
settings. Several factors hindering or facilitating timely initiation and completion of the process were identified. Timely
attendance required awareness, motivation and opportunity to attend. Women had to attend the health centre at the
right time and sometimes at the right gestational age to initiate the test, wait to complete the test and obtain the test
report in time to initiate further action. All these steps and requirements were influenced by factors within and outside
the health system such as getting right information from health care providers, clinic timings, characteristics of the test,
availability of transport, social network and support, and social norms and cultural practices.
Conclusions: Minimising and aligning complex stepwise processes of prenatal care and GDM screening delivery and
attention to the factors influencing it are important for further improving and expanding GDM screening and related
services, not only in Tamil Nadu but in other similar low and middle income settings. This study stresses the importance
of guidelines and diagnostic criteria which are simple and feasible on the ground.
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Background
Gestational diabetes mellitus (GDM) increases the risk
of various adverse pregnancy outcomes, as well as the
risk of future diabetes in both the mother and off-
spring [1–4]. According to estimates from the Inter-
national Diabetes Federation, approximately 21.4
million live births are annually affected by hypergly-
caemia in pregnancy of which 84% are affected by
GDM [5]. Despite the increased focus on GDM
screening and diagnosis in recent years, also in low
and middle income countries [6–8], very little is
known about the barriers and challenges faced by
women in this process, and how to implement or
improve GDM screening and care on a large scale in
such settings [9].
Based on work on diabetes and chronic disease
management, Mol [10] showed that what may seem a
simple process – the patient being informed about
the use of a medical technology (e.g. blood sugar
measurement), which he/she then uses to monitor
his/her disease – is far from straightforward. Mol ar-
gues that the problem is not in the decision-making
process (the patient was given the information and
choice to do the blood sugar measurement or not),
but in actually ‘doing’ the blood sugar measurement
[10]. In order for the ‘doing’ to take place, the cir-
cumstances have to be right, and the technology has
to be appropriate for the patient [11]. These issues
are rarely taken into consideration when evaluating
the use of diagnostic devices or test procedures and
receive little attention despite the significant impact
they have [11]. Thus, applying Mol’s notions of
‘doing’ to analyse the GDM screening process can
provide us with a deeper understanding of women’s
GDM screening experiences and behaviours.
India and in particular the South Indian state of
Tamil Nadu (TN) is a highly relevant setting for such
analysis: 65 million people in India are estimated to
have diabetes [5] and the country continues to strug-
gle with high maternal mortality and morbidity, ac-
counting for 19% of worldwide maternal deaths [12].
A high prevalence rate of GDM (14%) has been iden-
tified in TN, and has subsequently been noted in
other areas of India as well [13–15]. This led the
Government of TN to introduce GDM screening as
part of routine antenatal care (ANC) services at
government health centres in 2007, applying the cri-
teria recommended by the Diabetes in Pregnancy
Study Group India (DIPSI) [16], i.e. a single-step test
using a 75 g oral glucose tolerance test (OGTT) with
diagnosis being made if the two hour value is
140 mg/dl or more. Screening for GDM is typically
done in the 24–28th weeks of gestation, but some-
times also at the first ANC visit and it may also be
repeated later in pregnancy. Additionally, awareness
campaigns and capacity building initiatives targeted at
both the government and the private health care
system were carried out.
The health care system in TN as in rest of India is
complex; involving a mixture of public and private
health care providers (HCPs), practising different sys-
tems of medicine (modern, Ayurveda, Unani and Sid-
dha). In TN, only 53% of the population uses the
public health sector; with higher rates in rural
settings, and among the poor [17]. The organisation
of ANC services is also complex, with different levels
of services, facilities and specialisations in rural and
urban areas, and in the public and private sector.
There are no clear-cut referral systems, and women’s
use of ANC services depend on their practical access,
willingness and ability to pay for services. Many
women attend both public and private health care
services [18]. Other factors that determine utility of
maternal health services in India include women find-
ing the service relevant to themselves and their fetus/
child, quality of care [19], their socio-economic status
[20–22], distance to health facility, literacy, parity, ob-
stetric history [23], husband’s knowledge and attitude
towards services [24], family traditions, financial
constraints, behaviour of HCPs [25], and women’s au-
tonomy [26]. Thus, accessing and utilising services is
much more complex than merely a question of
awareness.
Implementing timely and effective detection and man-
agement of GDM in TN requires a good understanding
of how women navigate their way through the complex
health system. Therefore, our study investigated factors
that might influence timely initiation and completion of
the GDM screening and diagnosis process in a sample of
urban and rural women in TN.
Methods
Study area
The study was carried out in two areas of TN: Chennai
city and Thiruvallur district representing two different
settings for GDM screening: a private urban and a
government rural centre [27].
Chennai is the state capital, is currently experiencing
substantial economic growth and is home to a growing
middle class. In Chennai city, the study was conducted
at a private diabetes hospital catering mainly to the
urban middle class.
In Thiruvallur district, the study was conducted at a
government primary health centre and its surroundings,
located in a semi-rural area approximately 40 km north of
Chennai city. However, most pregnant women attending
ANC here reside in rural areas. While some inhabitants in
the area work in Chennai, many are farmers, daily wagers
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or workers at the local factories. The villages are
connected to the main roads via small paved or dirt roads.
Data collection, analysis and ethical considerations
Data for this study was collected between January 2013 and
September 2014 as part of a larger study on GDM [27].
The study was qualitative with triangulation of several
data sources and methods: observations at health facil-
ities, and interviews with pregnant women and HCPs.
This approach aimed at providing a holistic picture of
the investigated phenomenon, while increasing validity
and reducing the risk of bias [28].
Around 120 h of observation were conducted (by the
lead author KKN) at the two health centres, with a focus
on the screening process and patterns of actions as well
as verbal and non-verbal interactions. Detailed note-
taking was done. Observations provided contextual
knowledge about the health system and organisation of
services and highlighted issues from a third party per-
spective that informants (users and provider of services)
take for granted and therefore do not mention in
interviews [29].
Semi-structured interviews were conducted with 30
pregnant women attending ANC at the rural govern-
ment primary health centre (18 women) and the private
urban diabetes centre (12 women). An overview of the
women is presented in Table 1. A purposive sampling
strategy was used, and all the pregnant women had or
were supposed to have undergone GDM screening
procedures at the health centres during their current
pregnancy. They were recruited at the health facility,
through the local village health nurses or through refer-
ral from other pregnant women. Recruitment was con-
tinued until theoretical saturation was reached. The
interviews took place at a private area of the health
centre or at the women’s homes and focused on their ex-
periences with and perceptions of GDM screening ser-
vices (Additional file 1).
Additionally, interviews with nine HCPs were carried
out (four laboratory technicians, two village health nurses,
one physician, and two private practicing gynaecologists/
obstetricians). These HCPs were selected based on having
a crucial role in the screening process. The interviews fo-
cused on their experiences in providing GDM screening
services and challenges and opportunities in doing so
(Additional file 2). A few village health nurses approached
for interview declined, stating lack of time as the reason.
Informants fluent in English were interviewed by
KKN, but the majority of interviews were conducted
with support of a trained research assistant fluent in
both English and Tamil. The overall purpose of the study
was described to the participants, and verbal informed
consent obtained prior to the interview, including ap-
proval for audio recording the interview. Verbal consent
was chosen over written consent as obtaining written
consent was seen as counterproductive to the informal
and comfortable atmosphere we were trying to create to
facilitate rapport and building trust between the
researchers and informants [30]. The verbal informed
consent was given in the presence of KKN and the re-
search assistant. Ethical approval for the study, including
the use of verbal informed consent, was given by the
Institutional Ethics Committee at Dr. Seshiah Diabetes
Research Institute and Dr. Balaji Diabetes Care Centre
in Chennai.
The interviews, most lasting between 30 and 60 min,
were transcribed verbatim and translated into English.
The interview guides for the research intended to ex-
plore a number of overall topics, e.g. experience with the
process, social support and informants’ knowledge and
expectations of the GDM test. An iterative-inductive
analysis process [31] was followed, starting during
fieldwork, which allowed follow-up and collection of
additional data on emerging issues. Qualitative content
analysis of interview and observation data was done by
KKN, who read through and organised data into mean-
ing units, categories and themes [32]. The coding was
done using the software programme NVivo 10 (QSR
International Pty Ltd. 1999–2012). First step of the ana-
lysis was to describe the differences in GDM screening
and diagnosis procedures and compare these with
government order instructions. Next step of the analysis
identified two overall steps with two and three sub-
steps, respectively. At each sub-step there were certain
requirements or ‘doing’ as well as factors influencing
women’s navigation of the process (Fig. 1).
Results
Procedures for GDM screening and diagnosis
Data from observations and interviews with HCPs was
synthesised on the actual procedures of GDM screening
in the urban and rural health systems and compared to
government order instructions on screening for
hyperglycaemia in pregnancy (see Table 2). This analysis
revealed several differences in GDM screening ap-
proaches: 1) different testing ‘procedures’ 2) different
timing of GDM testing and 3) different diagnostic
criteria and procedures.
At the rural government centre, GDM screening was
carried out by a government employed laboratory
technician as well as by a private-non-profit employed
laboratory technician, working for a larger study on
GDM (see Balaji et al. 2014). As shown in Table 1, the
GDM screening process differed somewhat between the
two categories of laboratory technicians at the rural
centre. For testing by the government laboratory techni-
cian, the women had to attend in the fourth, sixth and
eight months of pregnancy, whereas no specific
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gestational age was required for testing by the private-
non-profit rural laboratory technician or at the urban
site. A 75 g OGTT was used at all sites. A fasting venous
sample was collected both at the urban centre and by
the private-non-profit employed laboratory technician at
the rural centre. At these two sites plasma glucose was
also estimated at one and two hours after intake of the
glucose solution. At the urban centre both of these were
measured in venous samples, whereas the private-non-
profit employed laboratory technician at the rural centre
measured the one hour plasma glucose with a calibrated
glucometer (capillary sample), and the two hour meas-
urement was on venous blood sample. The government
employed laboratory technician only took one sample: a
two hour venous sample after ingestion of 75 g glucose
load. At the urban centre the women were asked to wait
for the results of their test and were given the results the
same day, whereas women attending the rural centre got
the results after a couple of days to weeks later. These
differences are important and have consequences for
large scale implementation as described later.
Analysis of the observational and interview data
showed that at all sites two main steps had to be
completed in order to ensure timely screening and
diagnosis: 1) attending the health centre, and 2) initi-
ating, completing and getting the test report. The
Table 1 Characteristics of the pregnant women interviewed
Area Age Education Gestational age at first test
Woman 1 Urban 35 Graduate 2.5 months
Woman 2 Urban 23 12th Grade 4.5 months
Woman 3 Urban 31 Postgraduate 1.5 months
Woman 4 Urban 29 Postgraduate 1.5 months
Woman 5 Urban 23 Graduate 2 months
Woman 6 Urban 26 Postgraduate 2 months
Woman 7 Urban 25 Postgraduate 1 month
Woman 8 Urban 20 12th Grade 9 months
Woman 9 Urban 38 8th Grade 2 months
Woman 10 Urban 28 Postgraduate 3 months
Woman 11 Urban 25 Postgraduate 1 month
Woman 12 Urban 26 Graduate 3 months
Woman 13 Rural 28 12th Grade 8 months
Woman 14 Rural 25 8th Grade 7 months, but did not complete
Woman 15 Rural 23 9th Grade 5 months
Woman 16 Rural 22 10th Grade 7 months
Woman 17 Rural 21 10th Grade 3.5 months
Woman 18 Rural 22 Graduate 3 months, but did not complete
6 months when it was completed
Woman 19 Rural 22 9th Grade 4 months
Woman 20 Rural 20 7th Grade 4 months
Woman 21 Rural 22 10th Grade 5 months, but did not complete
Woman 22 Rural 24 Postgraduate 6 months
Woman 23 Rural 23 12th Grade 7 months
Woman 24 Rural 25 10th Grade 4 months, but did not complete
6 months when it was completed
Woman 25 Rural 26 12th Grade 7 months
Woman 26 Rural 25 10th Grade 4 months, but did not complete
5 months when it was completed
Woman 27 Rural 25 8th Grade 6 months
Woman 28 Rural 23 10th Grade 5 months
Woman 29 Rural 22 10th Grade 4 months
Woman 30 Rural 21 10th Grade 3 months
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government employed laboratory technician at the
rural centre required an extra step where a second
test was administered; which meant a repetition of
the two main steps (Table 2). Each step had sub-steps
and certain requirements or ‘doing’ for completion,
and various factors outside and within the health
system influenced whether such ‘doing’ took place
(see Fig. 1 and Table 3).
Overall, interview data showed that women’s experi-
ences of the screening process often differed based on
rural or urban contexts. This was partly influenced by
the differences in the screening procedures, but also by
differences in infrastructure and access, and socio-
economic backgrounds of the women as described in
the following sections.
Step 1: Attending the health centre for the test
The first step in the process had two sub-steps: 1.a de-
ciding to undertake the test and 1.b actually going for
the test.
1.a). Deciding to undertake the test: Awareness and
motivation
The analysis of the interviews with pregnant women and
the HCPs identified that being aware of the test, inclu-
ding whether and why one had to undertake it, was the
first requirement for deciding to go for the test. In prac-
tice, this meant that the pregnant women had to receive
(correct) information about the test. This was usually
done by the HCPs, i.e. the gynaecologist/obstetrician, if
the women attended the urban diabetes centre, and the
local village health nurse or the laboratory technician, if
the women attended the rural government primary
health centre. According to HCPs, this information is al-
ways provided, usually at the first ANC visit. However,
six of the interviewed women from the rural area said
they had not been informed about taking the test from
their HCP – or if they had, it was only late in their
pregnancy. Most of them had heard about the test from
family or neighbours, or from other pregnant women at-
tending ANC at the health centre or at the local balwadi
(community pre-school and health post). A 26 year old
woman from the rural area gave the following account
of how she found out about the GDM screening test:
“Last week when I went for the regular check-up, I
saw the other women sitting in a group for some
test. So I asked them what test they were taking.
They said “sugar test”, and then I said “every
month they take it, right? With the regular blood
test?” The women said “yes”. She [the village health
nurse] hasn’t told me anything. She comes here to give
Fig. 1 Steps, sub-steps, and requirements in the GDM screening and diagnosis process, and influencing factors within and outside the health system
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us the vaccination and that’s all. We never see her in
that hospital. She never helps us… We ourselves go
and find out things.” (Woman no. 25, rural area).
This woman had been tested for GDM for the first
time three days before the interview at seven months
into her pregnancy. Two other women from the rural
area similarly had the first test done in 7th and 8th
month, having not been informed about the test earlier.
In the rural area, not receiving timely information about
the test would thus delay or rule out testing entirely,
clearly illustrating how dependent screening is on proper
Table 2 Procedures for GDM screening and diagnosis synthesised based on observations, interviews, and available written
information, versus instructions from government order on screening
Private urban centre Government rural
centre - performed
by private-non-profit
laboratory technician
Government rural
centre -performed
by government l
aboratory technician
Government order
on screening for
hyperglycaemia in
pregnancy
Step 1:
Attending the
health centre
for the test
Informed and
referred for
the test
Via the gynaecologist/
obstetrician
Via the village health
nurse
Via the village health
nurse
Not mentioned
Step 2:
Initiating,
completing
and getting
the report of
the test
Attending
days
Fasting on
Mondays-Saturdays
Fasting on Tuesdays No-fasting on Thursdays 1) Irrespective of
whether she has
taken her breakfast
or not
Attending
time
Morning Morning Morning 2) Not mentioned
Gestational
age at
attendance
No specific gestational
age required, but testing
is recommended in each
trimester
No specific gestational age
required, but testing is
recommended in each
trimester
4th, 6th and 8th month
of pregnancy
3) Gestational
week 24–28
Flow of the
testing
procedure
1) Register
2) Consultation with
doctor
3) Pay bill
4) Give fasting venous
sample
5) Drink prepared
glucose solution
6) Wait 1 h
7) Give 1 h venous
sample
8) Wait 1 h
9) Give 2 h venous
sample
10) Have breakfast
and wait for results
1) Register
2) Give fasting venous sample
3) Mix and drink glucose
solution
4) Wait 1 h
5) Give 1 h capillary sample
6) Wait 1 h
7) Give 2 h venous sample
8) Go home or wait for
regular ANC check-ups
1) Register
2) Drink prepared glucose
solution
3) Wait 2 h
4) Give 2 h venous sample
5) Go home
4) Registration not
mentioned
5) Drink 75 g
glucose solution
6) Wait 2 h
7) Give 2 h venous
blood sample
Getting the
test report
On the day of the test.
Around 1.5–2 h after
2 h sample
Usually 1 week later If plasma glucose value is
140 mg/dl or more laboratory
technician informs village health
nurse who informs woman to
come back fasting for a second
test
Not mentioned
Diagnosis Steps of
confirming
test/s step to
be completed
A second test not
requested as diagnosis
is based on first test
A second test not
requested as diagnosis
is based on first test
1) Register
2) Fasting venous blood sample
3) Have breakfast consisting of 4
idlys (lentil and rice cakes).
4) Wait 1.5 h
5) Give 1.5 h venous sample
6) Go home
A second test not
requested as diagnosis
is based on first test
Diagnostic
cut-off levels
used
2 h plasma glucose
value ≥140 mg/dl
(7.8 mmol/l)
2 h plasma glucose
value ≥140 mg/dl
(7.8 mmol/l)
Fasting plasma glucose value
≥110
mg/dl (6.1 mmol/l) 1.5 h plasma
glucose value ≥140 mg/
dl (7.8 mmol/l))
Both values have to be above
the cut-off
2 h plasma glucose
value ≥140 mg/dl
(7.8 mmol/l)
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and timely information by HCPs. On the other hand, it
also reveals the importance of social network of women,
and how they can function as facilitators; in this case for
conveying information about the screening test, and,
thus, compensate for the shortcomings of the health sys-
tem. In the urban area, women also relied on their social
network such as family and friends – but mainly when
choosing obstetrician or maternity clinic, rather than as
sources of screening information.
The second requirement for initiating testing was
motivation to attend for testing. Once aware of the pos-
sibility for getting tested, most interviewed women dis-
played great motivation for the test. The motivation and
decision to undertake the test was strongly influenced by
the HCPs advice. Around 1/3 of all the women said they
did the test mainly because their HCP had sent them for
it and because they considered it to be compulsory.
“The doctor made this report, and that I have
followed. Because it was just a blood test. When the
doctor was saying “take it” and wrote it in the report
and everything, that way I knew [about the GDM
screening test]. The doctor has written this, so I follow
their rules.” (Woman no. 3, urban area).
“I asked her [the village health nurse] what to do. She
said that “tomorrow everyone will be doing the test.
You too go and do it”.” (Woman no. 13, rural area).
Motivation was also strongly linked to the fear of
the consequences of GDM and a strong desire to do
whatever possible for the fetus’ health. By doing the
test, women saw an opportunity to prevent a danger
at an early stage. Not taking the test was considered
hazardous, risking harmful effects to the baby.
“We should do the sugar test. Only if we do it, we
would have a healthy baby… If not, the baby would be
born very big… We would have to do a caesarean, and
if we have sugar, the place where the stitches are being
put, would not heal fast. So we have to do a sugar test
to check if we have sugar. Because if we have sugar
even the baby would get it. If we do the test it’s for the
good of the child.” (Woman no. 15, rural area).
Table 3 Barriers and facilitators for completing the two steps of the GDM screening process
Steps Barriers Facilitators
Step 1
Attending the health centre
• Not being informed (timely)
about test by HCP
• Weak or lack of social network
• Being informed (timely) about test by HCP
• Strong social network
• Strong motivation
• Awareness of risk
• Social norms about pregnancy and motherhood
• Belief in importance of compliance with instructions
from health care providers
• Unsupportive family
• Work
• Feeling unwell
• Being away from home
• Family in support of test
• Conducive clinic timings
• Lack of family member to accompany
or help with household work
• Family member to accompany or help with
household work
Step 2
Initiating, completing and
getting the report of the
screening and diagnostic
test in a timely manner
• Not being aware of test time schedule
• Lack of or delayed transportation and
heavy traffic
• No help with household work
• Inflexible interpretation of timing of test
in terms of gestational age
• Awareness of test time schedule
• Available and timely transportation and
conducive traffic
• Help with household work
• Glucose solution eliciting vomiting
• Procedure stating that test has to be
cancelled and done another day when
women vomit
• Adding lemon drops to glucose solution
• Long waiting time
• Uncomfortable physical ambience of
health centre and attitude of staff
• Health care provider not informing
the women about how and when the
results will be available
• Health care provider not informing
the women about the results within a
reasonable time period
• Barriers mentioned under step 1
when women have to return to the
health centre again
• Comfortable physical ambience of health centre
and attitude of staff
• Health services being free of charge
• HCP informing the women about how and when
the results will be available
• HCP providing the results to the women over
the phone or in-person in the village
Nielsen et al. BMC Pregnancy and Childbirth  (2017) 17:255 Page 7 of 13
The prominence of motherhood was also mentioned
in many interviews as a motivator for testing. Women
stressed their new role as responsible mothers, and how
GDM could potentially hamper the delivery of a healthy
baby, and thereby risk the discontinuation of the family.
Not handling this risk, could also lead to social stigma
through gossip, particularly in the rural area, as aptly
described by one woman: “Becoming a mother is a big
thing. So then if there is a problem [such as GDM] it
would be sad only. It is like going through pain and then
having another generation, and then if we don’t deliver
the baby well, the neighbours and all would talk badly
about us.” (Woman no. 29, rural area).
Finally, deciding to attend the test was strongly influ-
enced by the family. Almost all women from the rural
area and around half of the urban women lived in joint
families, typically with their in-laws, as is common in
India. Many women in both areas said that their families
would encourage and endorse them to undertake not
only the GDM screening test, but all other tests and
scans required during pregnancy.
“My parents, my husband, my mother-in-law, father-
in-law, they all said “take all the tests, because this is
the time to get the whatever, so you should be very
careful this time. So whatever the doctor say, you
should take that test. Whatever they say, you should
follow that”.” (Woman no. 5, urban area).
Many women explained that they had to seek the
approval of their husband and/or mother-in-law be-
fore going to the test, who had given it willingly –
particularly as the testing was instructed by the HCP
as part of routine ANC.
“For them it was just like “okay this is the protocol
now. These tests are done for everybody, so it is good.
You can rule it out now or take care from now”. So
they have been quite understanding about it as well.”
(Woman no. 4, urban area).
Only two of the interviewed women (women no. 18
and 25, both from the rural area and newly married)
gave accounts of how family members had been less
enthusiastic about the test. The family was either
concerned about the risk of evil spirits when pregnant
women travel or about the drawing of blood. Low
haemoglobin level is known in Tamil language as
having ‘less blood’, and anaemia among women is very
prevalent in this population. Thus, ‘drawing of blood’
seemed contradictory to these family members ac-
cording to the pregnant women. Yet, both women
also had family members supporting them in atten-
ding the test, and eventually the women disregarded
the concerns and attended the GDM screening test.
These findings highlight that having a supportive,
well-informed family is clearly an important facilitator
for GDM testing.
1.b). Going for the test: Having the opportunity to go
Having decided to go for the test, women encountered
the first ‘doing’ of the screening procedure: actually
going for the test. This required they had the opportunity
to go, which was influenced by several factors (Fig. 1
and Table 3).
The women’s well-being during pregnancy was one
such issue, which could delay going for the test. In inter-
views, some women from both areas mentioned that
pregnant women were not supposed to travel since it
could harm the fetus, and a few women explained that
they had delayed the test because of vomiting or tired-
ness. A 28 year old woman, attending the urban centre
for her first GDM screening test in the beginning of her
third month, said:
“My gynaecologist told me to go [for the test] by the
beginning of the second month. She said to go
whenever I feel a little okay and when the nausea is
all down and all that. But then it didn’t seem to come
down at all, and I was constantly throwing up and I
was taking drips. There was no way I could come to
this place [health centre] that early in the morning. It
was impossible. So I had no chance of coming here for
the diabetes test. But now, for the past two weeks, I
was a little okay, so we just thought we will finish it
off.” (Woman no. 10, urban area).
Another challenge was coordinating the test with job
timings, especially for urban women with formal jobs.
One informant, a 26 year old accountant pregnant for
the first time, was working nightshifts in a US company
in Chennai and said: “If I have to go for a night shift, I
can’t do the test. I won’t have sleep. From morning to the
evening I have to sleep, and night I have to go for night
shift. So, since I have taken leave, I am feeling relieved.”
(Woman no. 12, urban area).
This woman had taken one week’s unpaid leave in
order to rest and finish the required ‘doing’ of pregnancy
tests, including the GDM test. The urban centre was
also open on Saturdays, and from observations and in-
formal conversations it was clear that this helped many
working pregnant women to come for the test (including
woman no. 4 and woman no. 6 in this study).
Women without formal jobs had to coordinate testing
attendance with household work and child care. Women
living in joint households sometimes noted that their
family had helped them free up time from household
work to go for the test. A couple of women felt bad
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about asking for such help, and one woman noted that:
“To leave my child at home – I find it difficult.” (Woman
no. 15, rural area). Some rural women therefore brought
the child along with them to the health centre, which
they were generally allowed to, but which could compli-
cate completion of the second step of screening.
These factors were further aggravated by the fact that
many women due to social norms needed to be accom-
panied by family members when travelling. This meant
more coordination and potential delay. The need to have
a person accompanying the pregnant woman was de-
scribed by women as also being practical, e.g. securing
transportation, social and for security, e.g. assistance if
falling ill.
Difficulties with organising this were reported by a few
women in the rural as well as urban settings. One 20-
year old pregnant woman reported that it had taken her
two months and a lot of arguing with her husband, from
when she was advised to attend the test by her
gynaecologist, till she could go to the test:
“I used to shout at him for not taking me. “When will
you take me?” To take me here to check the sugar.
When he came back from his native place I somehow
told him to take me today. So [this] morning he
brought me. I used to fight with him. “You take me to
the doctor! Take me to the doctor!”.” (Woman no. 8,
urban area).
A final reason not to undertake the test, according to
HCPs, was the common Indian practice where women
go to live in their parental home sometime during preg-
nancy. If the parental home was located in another
health district, the women would not fall under the care
of their usual health centre and could miss the screening
notifications from their HCPs: “Some of them would say
that they have gone out of station [left their home], and
that they could not do the test… I would tell them to do
the test compulsory in the fourth month. Every month
when they come for the test, I would check their notebook,
and when I ask them why they didn’t come in the fourth
month, they would say that they had gone out of station.”
(Government laboratory technician, rural health centre).
However, the interviewed women themselves mainly
reported this as a reason why they did not collect the
test results.
Step 2: Initiating, completing and getting the test report
In spite of the identified barriers, all interviewed women
had managed to attend the health centre at least once
for the GDM screening. Upon arrival at the health
centre, the women had to meet other requirements for
the sub-steps: 2.a being allowed to initiate the test, 2.b
complete the test and 2.c getting the test report (Fig. 1).
2.a). Allowed to initiate the test: Attending at correct time
and gestational age
Even if the pregnant women arrived at the health centre,
particularly at the rural health centre, there were situa-
tions where the women were not allowed to take the
test. Observations showed that in the urban centre and
in the rural centre, when conducted by the private-non-
profit laboratory technician, the test procedure was typ-
ically organised to be done early in the morning during
a specific timeslot, with the women being fasting. Some
women arrived too late and were therefore refused or at
least strongly encouraged not do the test, and instead
told to come back another day. Interviews provided
more knowledge about why some women had problems
complying with this aspect of ‘doing’ the test. A 25 year
old woman from the rural area, who was first screened
when six months pregnant, described how she had
attended the test in her fourth month, but was refused
the test:
“I came [for the GDM test], but they told me that “it
has become late” and they told me that “we can’t do
the test”. So I went back home. I travelled so far, and
then when I came here I could not take the test since it
was late. Because that day the bus came late.”
(Woman no. 24, rural area).
Thus, transportation issues as well as not being aware
of the test timings, and completing household work were
other challenges mentioned by women for their inability
to reach the centre in time.
One of the HCPs described how he was often faced
with women coming too late: “If they come for the test at
10 o’clock, the test would be over at 12 o’clock, so they
have to wait till 12 o’clock. They would say that they will
wait, but I can’t wait, because I have to give the samples
at the hospital. The other patients would have come at 8
o’clock, so then I need to speak to the patient and make
her understand. At that moment the patient would be
sad and upset. She would feel all her effort to come to
take the test was in vain. So this is the problem that I
face.” (Private-non-profit laboratory technician, rural
primary health centre).
However, the women, who arrived in time for the test
with the government employed laboratory technician,
could still be turned down if they were not in the fourth,
sixth or eight month of pregnancy. A 22 year old
woman, five months pregnant with her second child,
said she had been tested when pregnant with her first
child. But in this pregnancy she had received contradic-
ting advice from the HCPs about when to do the test:
“Last week a neighbour of mine did the test. They [the
HCPs] told her that you have to do the sugar test in the
fifth month… and [they] told me to go for the test”.
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Arriving at the health centre, she was refused the test by
the laboratory technician, who blamed her she had
missed testing in the fourth month of pregnancy: “He
told me that only the sixth month women should do the
test and not the fifth month women. It made me sad. If I
don’t take the test this month, I will have to come back
the next month.” (Woman no. 21, rural area). The la-
boratory technician confirmed in an interview that he
would assign new testing dates for all women coming
for testing at incorrect gestational age. Thus, strict inter-
pretations of guidelines and unaligned advice given by
HCPs sometimes posed barriers for the pregnant women
to initiate the test.
2.b). Completing the test: Drinking glucose solution,
drawing of blood and waiting
Some women, who initiated the test, failed to complete it.
For instance, if they vomited after drinking the glucose so-
lution some women were told to go home and return for
a new test another day. Furthermore, in practice, the test
would take a whole day to complete with travelling, drink-
ing the glucose solution, drawing of blood, waiting at least
two hours for the test to be completed, and travelling
back. Urban as well as rural women found the waiting
time very long and arduous, and some rural women com-
plained about the facilities at the health centre being
crowded, dirty, and with too few and sometimes rude
staff: “They are doing it for our good only, but at times I
think if I have to go in this hot sun for all these tests. I feel
it hard. I would feel giddy. I would feel as of vomiting. I
would start at 7 and there would be a big crowd of 50
women, who would be waiting to do the tests.” (Woman
no. 18, rural area). For rural women, the test being free
of charge was the main reason for attending the
specific centre. In contrast, the urban women had few
complaints about the physicality of the centre, but
still found the waiting time long: “I didn’t know I
would be dedicating a whole day for this, but it looks
like I have.” (Woman no. 4, urban area).
2.c). Getting the test report and potential diagnosis in a
timely manner: Awareness, waiting and returning
After completing the test, there was still some ‘doing’
left. At the rural government centre, the laboratory
technicians would inform the pregnant women of the
test results via phone, through their village health nurse,
or more commonly tell the women to collect the test re-
port at the next ANC visit, typically between a week to a
month later. Being informed about the results meant
being told if the test results ‘were normal or not’. There
was no mentioning of this in the government order, and
one of the laboratory technicians described the proce-
dure he followed:
“If the patients wait on the same day for the results it
would become late… If it’s an abnormal case [GDM]
we would first inform the village health nurse to tell
the woman to come, and we would then refer the
woman to the General Hospital [in Chennai] on the
same day... The other pregnant women would collect it
when they come for the next check-up.” (Government
laboratory technician, rural centre).
However, in a few cases it took longer before the
women were informed. Among the reasons for this were
that the women had not been informed about how and
when to collect the report; wherefore they were not
aware that they were supposed to return. Some women
had been told to return to the health centre, but found it
difficult to repeat all the required arrangements.
At the private centre the women would get a 3–5 min
consultation with the doctor, who would inform the
woman whether the results were high or not, give in-
structions for what to do next and answer any questions
the woman or her accompanying family member would
have. However, this required that the woman would stay
at the health centre after the test and wait typically an-
other 1.5–2 h for the blood samples to be analysed and
for consultation with the doctor. It was observed that
some women left the health centre after completing the
test, without waiting for the report. Informal conversa-
tions during those observations indicated that they did
so because they had to return to work or more often out
of considerations for the accompanying person.
Discussion
The complex screening process
This study explored the factors that influence the GDM
screening process in TN, India. Limited research has
been conducted on the factors influencing GDM screen-
ing initiation and completion in low and middle
resource settings [9], and to our knowledge this is the
first study, which includes pregnant women’s own
perspectives.
Similarly to Mol’s work, we have shown that the GDM
screening process requires a substantial amount of
‘doing’ and navigation of the health system by pregnant
women, who have to go through several phases and sub-
steps, each of which is influenced by several factors
within and outside the health system. Other studies of
maternal health have proposed similar steps-based
frameworks for understanding barriers to health services
use. Thus, ‘the three phases of delay’ framework sug-
gested by Thaddeus and Maine, to understand barriers
for seeking ‘institutionalised birth’, [33] describes three
delay-steps: (i) dealing with the decision-making process
involved in seeking health care, (ii) reaching a health fa-
cility and (iii) receiving adequate care once at the facility.
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Our study indicates that completion of GDM screening
requires attendance of diverse services, at specific places
at specific time points, including several repetitions,
making it much more complex to successfully complete
the screening procedure than the chronological ‘delay
model’ suggest. These findings stress the importance of
minimising and aligning the required ‘doing’ in scree-
ning and maternal health services. Complex and un-
aligned systems will surely fail to achieve the objective
that all women should be tested for hyperglycaemia dur-
ing pregnancy as stated by the International Federation
of Obstetrics and Gynecology in their document on
GDM [34].
The GDM diagnostic criteria currently being endorsed
in TN by the Government do not require the women to
be fasting and only requires one blood sample [16, 35].
It is, thus, a simpler process than many other existing
criteria and screening approaches. Concerns about the
feasibility of the main international guidelines in low
and middle income countries have been raised by a
number of groups [36–38], and this study further
stresses the importance of guidelines and diagnostic
criteria which are simple and feasible on the ground.
Women’s perception of the screening process
In an earlier study from our group, challenges for GDM
screening were investigated from the point of view of
implementing partners of GDM projects in low and
middle income countries [37]. Among the challenges
identified were difficulties in screening women during
the recommended time period, challenges in testing
women in the fasting state, scarcity of test consumables,
lack of equipment, and the screening procedure being
too time consuming [37]. From our current study, it is
clear that timing and waiting issues are considered prob-
lematic by both the pregnant women and HCPs. If the
screening process cannot be shortened, it could be better
utilised, e.g. by providing useful prenatal care. Also, the
study showed the immense importance of HCPs’ abilities
to properly inform and communicate with women:
discussion and dialogue between HCPs and women are
very important facilitators for screening.
But equally important is the ability of women to ac-
tivate and draw on social networks in order to
complete the screening process. Social network and
support as facilitators for health seeking have also
been identified in studies focusing on other diseases
and conditions [39–43]. The importance of this is fur-
ther emphasised through our findings that ‘fear’ of
not living up to social norms of being a good mother,
with attached social stigma, was a central underlying
motivating factor to attend the screening test. This
can be corroborated by other studies from India,
showing that women’s inability to give birth to a
healthy baby can be associated with stigmatisation
[44–46]. Thus, a simple focus only on the behaviour,
attitude etc. of the individual seems insufficient, and
efforts should be made to further engage families and
the local communities in ensuring the health of
pregnant women and in combatting social stigma.
In this study, we showed how women across urban
and rural divides in TN are highly motivated and
make great efforts to complete the GDM screening
test. But the findings also suggest that women with
weak social networks, little family support and with
poor access to the health centre are particularly vul-
nerable for not completing the process. This is much
in line with evidence on factors influencing the use of
general maternal health care in India (19;24–26). To
ensure that these women are tested for GDM and
receive treatment if needed, it is important that the
identified barriers are addressed and facilitators are
strengthened. This also requires actions within the
health system, with the rural health system in particu-
larly need of strengthening. It could among other
things be considered to further consolidate the role of
village health nurses, e.g. by equipping them with a
glucometer to perform screening at the village level –
literally at the women’s doorstep, accompanying the
pregnant women to the health centres, and further
train them to communicate effectively with women,
including delivering test results.
Study limitations
Our aim with this study was to explore how the process
of GDM screening in TN is navigated and experienced,
and what may cause or prevent delays or completion
throughout the GDM screening and diagnosis process.
We therefore sought to ensure maximum variation of
women’s living places, life circumstances, gestational age
at screening, and experiences with the GDM screening
process. All women interviewed had attended a health
centre at least once for GDM screening and had, there-
fore, all been able to overcome the initial barriers for
screening. We did not recruit any women who had not
attempted to attend the test at all. These women are
likely facing even more pronounced barriers than the
ones reported here.
The study presents findings from an urban private
diabetes centre and a rural government health centre.
Time and resources did not allow for more diversity,
such as urban government and rural private health
centres; hence, we chose the two health care settings
likely to illustrate the biggest contrasts for health
seeking behaviour and systems resources.
Most interviews were conducted with the help of an
interpreter, which inevitably introduces some challenges,
though the translator can also act as a co-researcher,
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adding local knowledge and assisting the interpretation
of data [47]. This was enhanced by careful training of
the interpreter, discussions after each interview and of
the verbatim transcriptions and translation of the Tamil
language into English.
Conclusions
Our study investigated factors that influence the
timely initiation and completion of the GDM screen-
ing process in an urban and a rural setting in TN.
Factors both within and outside the health system
were identified, including getting right information
from HCPs, clinic timings, characteristics of the test,
availability of transport, social network and support,
and social norms and cultural practices. These factors
should receive more attention in the future efforts to
continue improving and expanding the GDM services
in TN and the rest of India. Minimising and aligning
complex stepwise processes of prenatal care and
GDM screening delivery; mitigating barriers of wait-
ing, timing and communication; and promoting social
supportive facilitators for the screening process are
important for further improving and expanding GDM
screening – not only in TN but in other similar low
and middle income settings as well.
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